B
Braidwell Portfolio holdings
AUM
$2.92B
This Quarter Return
+20.95%
1 Year Return
-4.59%
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$3.1B
AUM Growth
+$3.1B
(+14%)
Cap. Flow
+$365M
Cap. Flow
% of AUM
11.77%
Top 10 Holdings %
Top 10 Hldgs %
37.76%
Holding
89
New
16
Increased
13
Reduced
14
Closed
12
Top Buys
| 1 |
Apogee Therapeutics
APGE
|
$77.2M |
| 2 |
Viking Therapeutics
VKTX
|
$58.5M |
| 3 |
CG Oncology
CGON
|
$49.6M |
| 4 |
AVDL
Avadel Pharmaceuticals
AVDL
|
$45.1M |
| 5 |
Intuitive Surgical
ISRG
|
$40.1M |
Top Sells
| 1 |
Immunocore
IMCR
|
$41.8M |
| 2 |
Day One Biopharmaceuticals
DAWN
|
$33.7M |
| 3 |
Lantheus
LNTH
|
$30.7M |
| 4 |
Keros Therapeutics
KROS
|
$25.3M |
| 5 |
Harrow
HROW
|
$18.2M |
Sector Composition
| 1 | Healthcare | 57.18% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
51
Harrow
HROW
$1.44B
| $1.67M | 0.05% | 125,967 -1,372,617 | -92% | -$18.2M |
|
52
Amgen
AMGN
$155B
| – | – | -58,200 | Closed | -$16.8M |
|
53
Compass Therapeutics
CMPX
$483M
| – | – | -317,761 | Closed | -$496K |
|
54
Denali Therapeutics
DNLI
$2.23B
| – | – | -461,769 | Closed | -$9.91M |
|
55
Dyne Therapeutics
DYN
$1.92B
| – | – | -755,811 | Closed | -$10.1M |
|
56
HilleVax
HLVX
$105M
| – | – | -203,407 | Closed | -$3.26M |
|
|
57
Immunocore
IMCR
$1.62B
| – | – | -611,365 | Closed | -$41.8M |
|
|
58
Lantheus
LNTH
$3.73B
| – | – | -495,100 | Closed | -$30.7M |
|
59
Merus
MRUS
$4.98B
| – | – | -370,679 | Closed | -$10.2M |
|
60
RAPT Therapeutics
RAPT
$188M
| – | – | -389,300 | Closed | -$9.67M |
|
61
Terns Pharmaceuticals
TERN
$609M
| – | – | -2,318,050 | Closed | -$15M |
|
|
THRD
62
DELISTED
Third Harmonic Bio
THRD
| – | – | -1,316,018 | Closed | -$14.4M |
|
63
Viridian Therapeutics
VRDN
$1.5B
| – | – | -323,102 | Closed | -$7.04M |
|